# The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects

> **NCT05607589** · PHASE1 · WITHDRAWN · sponsor: **Daewoong Pharmaceutical Co. LTD.**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DWP213388
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05607589
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10
- **Primary completion:** 2024-02-20
- **Final completion:** 2024-03-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawal of Clinical Trial due to Licensing Out
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05607589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05607589, "The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT05607589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*